Comparison of profound biotinidase deficiency in children ascertained clinically and by newborn screening using a simple method of accurately determining residual biotinidase activity

P. Suzanne Hart, Brian O. Barnstein, Julie R. Secor McVoy, Reuben Matalon, Barry Wolf

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We describe a method for more accurately determining residual biotinidase activity in sera of individuals with profound biotinidase deficiency. Using this method we found that there is a statistically significant difference in the means of residual serum enzyme activities of symptomatic children and those identified by newborn screening. A subgroup of children identified by screening have activities higher than any of the symptomatic population. These children may develop mild symptoms, may develop symptoms later in life, or may not develop symptoms at all.

Original languageEnglish (US)
Pages (from-to)41-45
Number of pages5
JournalBiochemical Medicine and Metabolic Biology
Volume48
Issue number1
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Biotinidase
Biotinidase Deficiency
Screening
Newborn Infant
Enzyme activity
Serum
Enzymes
Population

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Comparison of profound biotinidase deficiency in children ascertained clinically and by newborn screening using a simple method of accurately determining residual biotinidase activity. / Hart, P. Suzanne; Barnstein, Brian O.; Secor McVoy, Julie R.; Matalon, Reuben; Wolf, Barry.

In: Biochemical Medicine and Metabolic Biology, Vol. 48, No. 1, 1992, p. 41-45.

Research output: Contribution to journalArticle

@article{0dc0f0b682b54910a243b61f02e48f59,
title = "Comparison of profound biotinidase deficiency in children ascertained clinically and by newborn screening using a simple method of accurately determining residual biotinidase activity",
abstract = "We describe a method for more accurately determining residual biotinidase activity in sera of individuals with profound biotinidase deficiency. Using this method we found that there is a statistically significant difference in the means of residual serum enzyme activities of symptomatic children and those identified by newborn screening. A subgroup of children identified by screening have activities higher than any of the symptomatic population. These children may develop mild symptoms, may develop symptoms later in life, or may not develop symptoms at all.",
author = "Hart, {P. Suzanne} and Barnstein, {Brian O.} and {Secor McVoy}, {Julie R.} and Reuben Matalon and Barry Wolf",
year = "1992",
doi = "10.1016/0885-4505(92)90046-2",
language = "English (US)",
volume = "48",
pages = "41--45",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Comparison of profound biotinidase deficiency in children ascertained clinically and by newborn screening using a simple method of accurately determining residual biotinidase activity

AU - Hart, P. Suzanne

AU - Barnstein, Brian O.

AU - Secor McVoy, Julie R.

AU - Matalon, Reuben

AU - Wolf, Barry

PY - 1992

Y1 - 1992

N2 - We describe a method for more accurately determining residual biotinidase activity in sera of individuals with profound biotinidase deficiency. Using this method we found that there is a statistically significant difference in the means of residual serum enzyme activities of symptomatic children and those identified by newborn screening. A subgroup of children identified by screening have activities higher than any of the symptomatic population. These children may develop mild symptoms, may develop symptoms later in life, or may not develop symptoms at all.

AB - We describe a method for more accurately determining residual biotinidase activity in sera of individuals with profound biotinidase deficiency. Using this method we found that there is a statistically significant difference in the means of residual serum enzyme activities of symptomatic children and those identified by newborn screening. A subgroup of children identified by screening have activities higher than any of the symptomatic population. These children may develop mild symptoms, may develop symptoms later in life, or may not develop symptoms at all.

UR - http://www.scopus.com/inward/record.url?scp=0026733557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026733557&partnerID=8YFLogxK

U2 - 10.1016/0885-4505(92)90046-2

DO - 10.1016/0885-4505(92)90046-2

M3 - Article

VL - 48

SP - 41

EP - 45

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 1

ER -